[go: up one dir, main page]

ZA975827B - Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production. - Google Patents

Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.

Info

Publication number
ZA975827B
ZA975827B ZA9705827A ZA975827A ZA975827B ZA 975827 B ZA975827 B ZA 975827B ZA 9705827 A ZA9705827 A ZA 9705827A ZA 975827 A ZA975827 A ZA 975827A ZA 975827 B ZA975827 B ZA 975827B
Authority
ZA
South Africa
Prior art keywords
oral administration
production
active ingredient
benzimidazole derivatives
stable medicament
Prior art date
Application number
ZA9705827A
Other languages
English (en)
Inventor
Gerd-Ulfert Heese
Herbert Juenger
Arnim Laicher
Claudio Lorck
Thomas Profitlich
Gerd Weiss
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of ZA975827B publication Critical patent/ZA975827B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9705827A 1996-06-28 1997-06-30 Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production. ZA975827B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19626045A DE19626045C2 (de) 1996-06-28 1996-06-28 Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben

Publications (1)

Publication Number Publication Date
ZA975827B true ZA975827B (en) 1998-01-30

Family

ID=7798347

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9705827A ZA975827B (en) 1996-06-28 1997-06-30 Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.
ZA9705828A ZA975828B (en) 1996-06-28 1997-06-30 Stable medicament for oral administration and method for its production.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA9705828A ZA975828B (en) 1996-06-28 1997-06-30 Stable medicament for oral administration and method for its production.

Country Status (11)

Country Link
EP (1) EP0934058B1 (xx)
JP (1) JP4641075B2 (xx)
AT (1) ATE247457T1 (xx)
AU (2) AU3345197A (xx)
CA (1) CA2258918C (xx)
DE (2) DE19626045C2 (xx)
DK (1) DK0934058T3 (xx)
ES (1) ES2205243T3 (xx)
PT (1) PT934058E (xx)
WO (2) WO1998000114A2 (xx)
ZA (2) ZA975827B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DK1105105T3 (da) 1998-08-12 2006-07-17 Altana Pharma Ag Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US7316819B2 (en) * 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
KR100479637B1 (ko) * 2002-02-01 2005-03-31 한국화학연구원 란소프라졸을 함유하는 경구제제 및 그의 제조방법
DE10235475B4 (de) * 2002-08-02 2006-04-27 Ratiopharm Gmbh Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung
RU2332237C2 (ru) 2002-08-02 2008-08-27 Рациофарм Гмбх Фармацевтический препарат, содержащий производное бензимидазола, смешанное с микрокристаллической целлюлозой, и способ его изготовления
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
MXPA06000852A (es) * 2003-07-24 2006-03-30 Smithkline Beecham Corp Peliculas que se disuelven oralmente.
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
EP1721604A4 (en) * 2004-03-04 2008-04-30 Takeda Pharmaceutical STABLE CAPSULE PREPARATION
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MX2007008141A (es) * 2005-01-03 2007-12-10 Lupin Ltd Composicion farmaceutica de sustancias labiles en medio acido.
DE102005032806A1 (de) * 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
DE102006006532B4 (de) 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
JP5167345B2 (ja) 2007-05-07 2013-03-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤を加速放出する腸溶コーティングを含む固体剤形
DE102008056312A1 (de) 2008-11-07 2010-05-12 Biogenerics Pharma Gmbh Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz
DE102010052847A1 (de) * 2010-11-29 2012-05-31 Temmler Werke Gmbh Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
US8951996B2 (en) * 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
JP5934835B2 (ja) * 2013-03-08 2016-06-15 富士フイルム株式会社 腸溶性細粒及び医薬組成物
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
MX2020009428A (es) * 2018-04-12 2020-10-16 Bpsi Holdings Llc Revestimientos acidificantes y sustratos resistentes a la desintegracion revestidos con los mismos.
CA3160862A1 (en) 2019-12-11 2021-06-17 Priyanka HAKSAR Dosage form for use in treating or preventing of a disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS584730A (ja) * 1981-06-29 1983-01-11 Shin Etsu Chem Co Ltd 腸溶性コ−テイング組成物およびその製造方法
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
AU4513393A (en) * 1992-07-17 1994-02-14 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation

Also Published As

Publication number Publication date
ZA975828B (en) 1998-01-30
EP0934058A2 (de) 1999-08-11
DK0934058T3 (da) 2003-12-01
CA2258918C (en) 2005-11-22
AU3438897A (en) 1998-01-21
PT934058E (pt) 2004-01-30
DE59710629D1 (de) 2003-09-25
WO1998000115A3 (de) 1998-02-26
ES2205243T3 (es) 2004-05-01
DE19626045C2 (de) 1998-12-03
AU3345197A (en) 1998-01-21
JP4641075B2 (ja) 2011-03-02
WO1998000114A3 (de) 1998-02-26
WO1998000115A2 (de) 1998-01-08
WO1998000114A2 (de) 1998-01-08
ATE247457T1 (de) 2003-09-15
EP0934058B1 (de) 2003-08-20
DE19626045A1 (de) 1998-01-08
CA2258918A1 (en) 1998-01-08
JP2000514051A (ja) 2000-10-24

Similar Documents

Publication Publication Date Title
ZA975827B (en) Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
HUP0001382A2 (hu) Eritromicinszármazékokat tartalmazó, ezek késleltetett felszabadulását biztosító készítmények
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
AU5396379A (en) Cardiac glycoside composition
IE881916L (en) Press-coated dihydropyridine tablets
CA2232356A1 (en) Method of producing multi-layer medicaments in solid form for oral or rectal administration
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EP0130779A3 (en) Pharmaceutical composition suitable for intestinal administration
MX9500885A (es) Preparacion farmaceutica para administracion oral.
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
BG105173A (en) Novel salt form of pantoprazole
IE64850B1 (en) Therapeutically active substituted benzimidazole and process for its preparation
WO2000008007A3 (de) Cyclopentabenzofuran-derivate und ihre verwendung
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
EP0649660A3 (de) Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung.
ZA969319B (en) Derivatives of imidazole n-benzyldioxole, their preparation process, their use as medicaments, pharmaceutical composition and new use.
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
GB9420748D0 (en) 1,5 benzodiazepine derivatives
JPS6115829A (ja) 口腔粘膜適用徐放性ニフエジピン製剤